Radiation therapy has long been a cornerstone in the treatment of cancer, helping millions of patients worldwide fight malignant diseases. However, whilst this powerful treatment can be life-saving, it often comes with a significant cost: radiation tissue damage. The very mechanism that makes radiation therapy effective at destroying cancer cells can also harm healthy tissue surrounding the treatment area, leading to complications that may emerge months or even years after treatment has concluded.
For many patients who experience these delayed radiation injuries, hyperbaric oxygen therapy (HBOT) has emerged as a remarkable solution, offering hope and healing when conventional treatments fall short. This non-invasive therapeutic approach harnesses the power of oxygen under pressure to promote tissue repair, reduce inflammation, and restore quality of life for those suffering from radiation-induced complications.
Understanding Radiation Tissue Damage
Radiation tissue damage, medically termed radiation injury or radiation necrosis, occurs when the ionising radiation used to treat cancer inadvertently damages healthy cells and tissues in the treatment field. Whilst modern radiation techniques have become increasingly precise, some collateral damage to surrounding tissues remains unavoidable.
The injury manifests in two distinct phases. Acute radiation injury appears during or shortly after treatment, typically presenting as inflammation, redness, and discomfort. Most patients experience some degree of acute symptoms, which usually resolve within weeks to months following completion of therapy.
More concerning, however, is late or delayed radiation injury, which can develop months or years after treatment has ended. This occurs because radiation damages the small blood vessels and reduces the tissue’s ability to heal itself. The affected tissue becomes hypoxic (oxygen-starved), hypovascular (lacking adequate blood supply), and hypocellular (containing fewer healthy cells). This trio of conditions creates a chronic, non-healing wound environment that progressively worsens over time.
Common Types of Radiation Tissue Damage
Radiation tissue damage can affect virtually any part of the body that has received radiation therapy. Some of the most common and debilitating forms include:
Osteoradionecrosis (ORN) occurs when radiation damages bone tissue, most commonly affecting the jaw following treatment for head and neck cancers. The bone becomes devitalised and susceptible to infection, potentially leading to severe pain, exposed bone, and pathological fractures.
Radiation cystitis affects the bladder following pelvic radiation for prostate, bladder, cervical, or rectal cancers. Patients may experience frequent urination, urgency, pain, and haematuria (blood in the urine), which can significantly impact daily life.
Radiation proctitis involves inflammation and damage to the rectum and lower colon, causing rectal bleeding, pain, diarrhoea, and incontinence. This condition often follows radiation therapy for pelvic cancers.
Soft tissue radionecrosis can occur anywhere in the body, affecting skin, muscle, and connective tissue. These chronic wounds fail to heal through normal processes and may become increasingly problematic over time.
Radiation-induced fibrosis involves the replacement of healthy tissue with scar tissue, leading to stiffness, pain, and loss of function in the affected area.
The Science Behind Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy involves breathing 100% pure oxygen whilst inside a pressurised chamber, typically at pressures between 2.0 and 2.5 atmospheres absolute (ATA). This combination of increased pressure and concentrated oxygen creates physiological effects that are impossible to achieve through normal breathing.
At these elevated pressures, oxygen dissolves directly into the blood plasma, cerebrospinal fluid, and other bodily fluids, dramatically increasing oxygen delivery to compromised tissues. This hyperoxic state triggers a cascade of beneficial cellular and molecular responses that directly address the underlying problems caused by radiation damage.
The therapy promotes neovascularisation, the growth of new blood vessels into damaged, oxygen-starved tissue. By stimulating the release of growth factors and stem cells, HBOT helps rebuild the vascular network that radiation has destroyed, essentially reversing the hypovascular state that prevents healing.
HBOT also enhances fibroblast proliferation, encouraging these cells to produce collagen and other structural proteins essential for tissue repair. In the oxygen-rich environment created by HBOT, fibroblasts function more efficiently, accelerating wound healing and tissue regeneration.
Furthermore, the therapy exhibits powerful anti-inflammatory effects, reducing the chronic inflammation that perpetuates tissue damage. It also enhances white blood cell function, improving the body’s ability to fight infection—a critical benefit for patients with compromised, radiation-damaged tissue that is highly susceptible to bacterial invasion.
Clinical Evidence and Treatment Protocols
The use of hyperbaric oxygen therapy for radiation tissue damage is supported by substantial clinical evidence and has gained recognition from major medical organisations worldwide. The Undersea and Hyperbaric Medical Society (UHMS) lists several radiation injuries among the approved indications for HBOT.
Numerous studies have demonstrated the efficacy of HBOT for osteoradionecrosis, with success rates ranging from 70% to 90% when combined with appropriate surgical debridement. Research has shown that HBOT can prevent the progression of bone damage and significantly reduce the need for extensive surgical resection.
For radiation cystitis, clinical trials have reported improvement rates of 75% to 90%, with patients experiencing substantial reductions in haematuria and urinary symptoms. Similarly, studies on radiation proctitis have shown that HBOT can reduce rectal bleeding and improve quality of life for the majority of patients.
Treatment protocols vary depending on the specific type and severity of radiation injury, but typically involve 30 to 60 daily hyperbaric sessions, each lasting approximately 90 to 120 minutes. Some conditions may require maintenance therapy or additional sessions if symptoms recur.
The Marx protocol, developed specifically for preventing and treating osteoradionecrosis, involves pre-surgical hyperbaric treatments followed by additional post-operative sessions. This prophylactic approach has proven particularly effective for patients requiring dental extractions or jaw surgery following radiation to the head and neck region.
Patient Selection and Assessment
Not all patients with radiation tissue damage are suitable candidates for hyperbaric oxygen therapy. A thorough medical evaluation is essential to determine appropriateness for treatment and identify any contraindications.
Absolute contraindications include untreated pneumothorax (collapsed lung), whilst relative contraindications may include certain lung conditions, uncontrolled seizures, or claustrophobia. Patients taking specific medications, particularly certain chemotherapy agents, may need to discontinue them temporarily during HBOT treatment.
Successful treatment requires patient commitment, as the protocol demands daily attendance for weeks or months. However, for those who complete the recommended course of therapy, the potential benefits can be life-changing.
What to Expect During Treatment
Patients undergoing hyperbaric oxygen therapy for radiation damage typically attend daily sessions at a specialised hyperbaric facility. Treatment takes place in either a monoplace chamber (accommodating one person) or a multiplace chamber (accommodating several people simultaneously).
During the session, patients simply relax, breathe normally, and may read, listen to music, or watch television. The chamber pressure gradually increases over 10 to 15 minutes, during which patients may experience a sensation of fullness in the ears similar to descending in an aeroplane. Simple techniques, such as swallowing or yawning, help equalise ear pressure.
Once at treatment pressure, patients breathe pure oxygen for the prescribed duration, typically 60 to 90 minutes. The chamber then slowly depressurises over 10 to 15 minutes, allowing patients to exit comfortably.
Most patients tolerate HBOT extremely well, with minimal side effects. The most common issues are temporary and include ear or sinus discomfort, temporary vision changes, and mild fatigue. Serious complications are rare when proper protocols are followed and patients are appropriately screened.
Integrating HBOT with Conventional Care
Hyperbaric oxygen therapy is most effective when integrated as part of a comprehensive treatment plan. For radiation tissue damage, this often includes collaboration between radiation oncologists, surgeons, wound care specialists, and hyperbaric medicine physicians.
For example, patients with osteoradionecrosis may require surgical debridement of dead bone tissue in addition to HBOT. Those with radiation cystitis might benefit from combining HBOT with medications or other interventions. The multidisciplinary approach ensures that patients receive optimal care tailored to their specific situation.
Conclusion
Radiation tissue damage represents one of the most challenging consequences of cancer treatment, affecting patients’ quality of life long after their cancer has been successfully treated. Hyperbaric oxygen therapy offers a scientifically validated, non-invasive solution that addresses the fundamental pathophysiology underlying radiation injury.
By delivering oxygen at therapeutic pressures, HBOT reverses the hypoxic, hypovascular, and hypocellular state that prevents healing, promoting new blood vessel growth, enhancing cellular repair mechanisms, and reducing inflammation. The substantial body of clinical evidence supporting its use, combined with high success rates and minimal side effects, has established HBOT as a standard of care for many types of radiation tissue damage.
For patients struggling with the delayed effects of radiation therapy, hyperbaric oxygen therapy represents more than just a treatment—it offers renewed hope for healing, restored function, and improved quality of life. As awareness grows and access to hyperbaric facilities continues to expand, more patients can benefit from this remarkable therapeutic approach.